- Report
- July 2024
- 137 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- July 2024
- 138 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- July 2024
- 133 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- July 2024
- 130 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- June 2024
- 141 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- June 2024
- 144 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- June 2024
- 174 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- June 2024
- 171 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- June 2024
- 134 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- May 2024
- 163 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- November 2023
- 168 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- September 2022
- 120 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- November 2021
- 120 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- April 2026
- 143 Pages
India
From €2241EUR$2,499USD£1,922GBP
€3586EUR$3,999USD£3,075GBP
- Report
- February 2026
- 141 Pages
India
From €2241EUR$2,499USD£1,922GBP
€3586EUR$3,999USD£3,075GBP
- Report
- February 2026
- 137 Pages
Australia
From €2689EUR$2,999USD£2,306GBP
€3586EUR$3,999USD£3,075GBP
- Report
- August 2025
- 143 Pages
Global
From €2689EUR$2,999USD£2,306GBP
€3586EUR$3,999USD£3,075GBP
- Report
- May 2024
- 132 Pages
Global
From €2689EUR$2,999USD£2,306GBP
€3586EUR$3,999USD£3,075GBP
- Report
- June 2025
- 400 Pages
Global
From €4438EUR$4,949USD£3,806GBP
- Report
- June 2025
- 150 Pages
Global
From €2420EUR$2,699USD£2,075GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more